UNSPSC 51321704: Melinamide

This classification denotes an enzyme inhibitor with the molecular formula C26H41NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JJ07049A84, chemically known as 9,12-octadecadienamide, n-(1-phenylethyl)-, (z,z)- (9ci) but generally known as melinamide, which bears US NIH Compound Identifier 5282142. European Medicines Agency schedules Melinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08724MIG.

UNSPSC 51321704 Melinamide, a Commodity code, encompasses pharmaceutical products supplied to state and local emergency medical services, health departments, and multistate cooperative purchasing programs for direct clinical use and inventory replenishment. State and local governments procuring under this code buy emergency medications, generic pharmaceuticals, and over-the-counter products through sealed competitive bids, requests for proposal, and cooperative purchasing vehicles. Issuing bodies include city fire and rescue departments, state health and human services commissions, and multistate cooperative purchasing alliances serving participating state agencies and local facilities. The Tampa Fire Rescue procurement shows typical scope: emergency life support medications supplied with strict expiration-date maintenance, rapid delivery timelines, and warranty guarantees against defects. Cooperative vehicles like the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) expand reach across multiple states, requiring manufacturers to work through authorized wholesalers and maintain cGMP and Drug Supply Chain Security Act compliance. Tampa designated the opportunity with a Small Local Business Enterprise sheltered market 5 percent bid discount and required comprehensive accessibility and OSHA Safety Data Sheet documentation; MMCAP emphasizes price competitiveness (75 percent of evaluation weight), EDI capability, administrative fee compliance, and flexible net-pricing models.

Geographic activity centers on Florida and Minnesota with multistate reach through cooperative purchasing. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications with a due date of April 8, 2026, and estimated contract value of $40,000, seeking four medication line items (Labetalol, Epinephrine, Adenosine, Diltiazem) for Tampa Fire Rescue in Hillsborough County with one-year initial term and renewal options. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 due March 26, 2026, for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with contract effectiveness July 1, 2026, and two-year terms. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler arrangements—an exploratory procurement stage preceding formal solicitation. Recent activity reflects demand for reliable pharmaceutical supply chains supporting emergency services and state health programs, with emphasis on compliance documentation, wholesale distribution partnerships, and competitive pricing models.